Oric Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ORIC on Nasdaq
Industry
Pharmaceutical Preparations
Location
240 E. Grand Ave., 2 Nd Floor, South San Francisco, CA

Insiders trading volume in the past year

Oric Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pfizer Inc 10%+ Owner $46.2M Dec 23, 2022
Column Group II, Lp 10%+ Owner $30.6M Nov 12, 2021
Jacob Chacko PRESIDENT AND CEO, Director $7.38M -$3.07M -29.4% Oct 6, 2025
Richard A. Heyman Director $2.77M Oct 3, 2025
Dominic Piscitelli Chief Financial Officer $983K -$850K -46.4% Oct 6, 2025
Pratik S. Multani Chief Medical Officer $926K -$73.3K -7.33% Jan 2, 2025
Lori Anne Kunkel Director $435K Mar 3, 2025
Richard H. Scheller Director $336K May 20, 2021
Angie You Director $264K +$263K +23041% Jun 20, 2025
Mardi Dier Director Jan 2, 2025
Peter Svennilson Director, 10%+ Owner Jun 16, 2021
Carl L. Gordon Director, 10%+ Owner Jun 16, 2021
Steven L. Hoerter Director Jan 2, 2025

Recent Insider Transactions by Companies or Individuals for Oric Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.